PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $629,000 | -25.3% | 165,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $842,000 | +4.7% | 165,500 | +4.0% | 0.00% | 0.0% |
Q3 2019 | $804,000 | -15.5% | 159,100 | +3.2% | 0.00% | 0.0% |
Q2 2019 | $951,000 | +33.0% | 154,100 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $715,000 | +15.5% | 154,100 | +4.5% | 0.00% | 0.0% |
Q4 2018 | $619,000 | -33.0% | 147,400 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $924,000 | -6.1% | 147,400 | +20.4% | 0.00% | 0.0% |
Q2 2018 | $984,000 | +7.8% | 122,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $913,000 | +32.7% | 122,400 | +5.8% | 0.00% | 0.0% |
Q4 2017 | $688,000 | -19.2% | 115,700 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $852,000 | +8.4% | 115,700 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $786,000 | -28.0% | 115,700 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,092,000 | +9.2% | 115,700 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $1,000,000 | +36.6% | 115,700 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $732,000 | +50.0% | 115,700 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $488,000 | +0.2% | 115,700 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $487,000 | -15.9% | 115,700 | +22.4% | 0.00% | 0.0% |
Q4 2015 | $579,000 | +7.0% | 94,500 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $541,000 | -12.5% | 94,500 | +14.1% | 0.00% | -50.0% |
Q2 2015 | $618,000 | – | 82,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
SEARLE & CO. | 60,000 | $349,000 | 0.34% |
TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |